Full publication list
- Access to medicines and health products programme: annual report 2020 (2021)
- Access to new medicines in Europe: Final draft report (2015)
- Access to new medicines in Europe: technical review of policy initiatives and opportunities for collaboration and research (2015)
- Antimicrobial Medicines Consumption (AMC) Network. AMC data 2011–2014 (2017)
- Assessing non-prescription and inappropriate use of antibiotics (2019)
- Assessing the magnitude and nature of shortages of essential medicines and vaccines: focus on the WHO European Region (2020)
- Availability and affordability of medicines and assessment of quality systems for prescription of medicines in the Republic of Moldova (2012)
- Availability of medicines in Estonia: an analysis of existing barriers and options to address them (2016)
- Challenges and opportunities in improving access to medicines through efficient public procurement in the WHO European Region (2016)
- Changes to 2019 WHO Model List of Essential Medicines for adults (EML) and Model List of Essential Medicines for children (EMLc)
- Compendium of innovative health technologies for low-resource settings 2011, 2012, 2013 (2013)
- Consideration of cancer medicines as part of the revisions to 2019 WHO Model List of Essential Medicines for adults (EML) and Model List of Essential Medicines for children (EMLc): Section 8 - Immunomodulators and Antineoplastics
- Consideration of diabetes medicines as part of the revisions to 2019 WHO Model List of Essential Medicines for adults (EML): Long-acting insulin analogues
- Cross-country collaborations to improve access to medicines and vaccines in the WHO European Region (2020)
- Current status of health intervention and technology assessment in the Balkan region (2020)
- Developing and implementing guidelines for health policy and clinical practice in Estonia: interim appraisal of progress (2015)
- Evaluating attitudes and behaviours in the rational use of medicines in health-care services for refugees and migrants in Turkey (2021)
- Evaluation of the Affordable Medicines Programme in Ukraine (2019)
- Evidence brief for policy. Antibiotic prescribing in long-term care facilities for the elderly (2018)
- Expert meeting on market transparency to improve access to high-priced innovative medicines (2020)
- Health systems strengthening in the context of Health 2020: challenges and priorities in the WHO European Region (2015)
- Health Technologies and Pharmaceuticals (HTP) Programme - Annual Report 2015
- Health technologies and pharmaceuticals (HTP) programme annual report 2013 (2014)
- Health technologies and pharmaceuticals (HTP) programme annual report 2014 (2015)
- Health technologies and pharmaceuticals annual report 2012 (2012)
- Health technologies and pharmaceuticals programme annual report 2019
- Health technologies and pharmaceuticals programme. Annual report 2017
- Health technologies and pharmaceuticals programme. Annual report 2018 (2019)
- Health Technologies and Pharmaceuticals. Annual Report 2016 (2017)
- Health technology assessment and health policy-making in Europe. Current status, challenges and potential (2008)
- Health technology assessment: an introduction to objectives, role of evidence and structure in Europe (2005)
- Improved effectiveness of generic medicine markets in Hungary. Analysis and recommendations (2015)
- Improving access to medicines in primary care: nurse prescribing in Poland (2020)
- Interregional workshop in preparation for transitioning towards domestic financing in TB, HIV and Malaria response (Tbilisi, Georgia, 17–19 October 2018)
- Medicines reimbursement policies in Europe (2018)
- Pharmaceutical pricing and reimbursement reform in Kyrgyzstan (2016)
- Pharmaceutical pricing and reimbursement systems in Eastern Europe and Central Asia (2020)
- Post-market surveillance of in vitro diagnostics (2015)
- Promoting access to medical technologies and innovation
- Rationalizing distribution and utilization of high value capital medical equipment in Greece (2018)
- Regulation of Medical Devices: A Step-by-step Guide (2016)
- Report from technical working meeting on access to new medicines, 22–23 February 2017
- Selection of essential medicines at country level: using the WHO model list of essential medicines to update a national essential medicines list (2020)
- Strengthening the Health Systems Response to COVID-19 - Technical guidance #3, 6 April 2020 (produced by WHO/Europe)
- Strengthening the Health Systems Response to COVID-19 Technical guidance #4, 1 May 2020 (produced by WHO/Europe)
- Summaries of changes to the WHO Model List of Essential Medicines (EML) and Model List of Essential Medicines for children (EMLc) 2017 (2018)
- The legal and regulatory framework for community pharmacies in the WHO European Region (2019)
- The Oslo Medicines Initiative - Member States' statements in connection with the online consultations (2021)
- The Oslo Medicines Initiative - non-State Actors' statements in connection with the online consultations (2021)
- The role of pharmacist in encouraging prudent use of antibiotic medicines and averting antimicrobial resistance – a review of current policies and experiences in Europe (2014)
- WHO COVID-19 Essential Supplies Forecasting Tool (COVID-19-ESFT): frequently asked questions (FAQ), 24 April 2020
- WHO COVID-19 Essential supplies forecasting tool (COVID-ESFT), version 2
- WHO Global Model Regulatory Framework for Medical Devices including in vitro diagnostic medical devices (2017)
- WHO Regional Office for Europe advice on the use of experimental medicines for the treatment of COVID-19 patients, 9 April 2020
- WHO Regional Office for Europe Antimicrobial Medicines Consumption (AMC) Network. AMC data 2011–2017 (2020)
- WHO Regional Office for Europe Antimicrobial Medicines Consumption (AMC) Network: AMC data 2011–2017: executive summary (2020)
- WHO/Europe regional pharmaceutical situation report (2013)
